Susan Morrison, MD
Allergy & Immunology · Belleville, NJNPI 1174501886
Payments from drug & device makers
Across 42 payments — averaging $76.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$530
- CSL Behring$374
- AstraZeneca$222
- ADMA Biomanufacturing LLC$221
- Alk-abello, Inc$207
- Blueprint Medicines Corporation$175
- plus $1K from 14 others
What the payments were for
- Consulting fees$2217%
- Food & beverage$2,78887%
- Education$1896%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 5 | $530 |
| CSL Behring | 4 | $374 |
| AstraZeneca | 2 | $222 |
| ADMA Biomanufacturing LLC | 3 | $221 |
| Alk-abello, Inc | 3 | $207 |
| Blueprint Medicines Corporation | 2 | $175 |
| Regeneron Healthcare Solutions, Inc. | 2 | $169 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $160 |
| Optinose US, Inc. | 2 | $153 |
| Astellas Pharma US Inc | 2 | $145 |
| Merck | 1 | $124 |
| Biomerieux Inc | 1 | $121 |
| Ionis Pharmaceuticals, Inc. | 1 | $115 |
| Grifols USA, LLC | 1 | $104 |
| Novartis | 3 | $99 |
| Pfizer | 1 | $95 |
| Teva Pharmaceuticals USA, Inc. | 1 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $50 |
| Biocryst US Sales Co., LLC | 1 | $39 |
| Gilead | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,198 in reported general payments places this provider in the 45th percentile of 135 allergy & immunology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 18 | $97,794 |
| Dupixent SyringeDupilumab | 13 | $47,587 |
| Epinephrine | 28 | $7,799 |
| Dextrose In Lactated RingersDextrose 5%-Lactated Ringers | 17 | $3,367 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 19 | $2,545 |
| Montelukast Sodium | 102 | $1,495 |
| Mometasone Furoate | 18 | $1,255 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 44 | $1,004 |
| Ventolin HfaAlbuterol Sulfate | 12 | $671 |
| MetronidazoleMetronidazole/Sodium Chloride | 27 | $637 |
| Hydroxyzine Hcl | 20 | $575 |
| Ketorolac Tromethamine | 12 | $451 |
| Fluticasone Propionate | 36 | $386 |
| Azelastine Hcl | 20 | $386 |
| Famotidine | 24 | $369 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Belleville
- Mark WeinsteinBelleville$424K
- Ellen SherOcean$2.7M
- Andrew PedinoffSkillman$2.3M
- Bruce DecotiisBrick$647K
- Patrick PerinTeaneck$589K
- Peter RickettiTrenton$501K
- Jinping GuoMarlton$488K
- Tina ZeccaLittle Silver$407K
- John KimMedford$339K
- George BelecanechVoorhees$208K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.